FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

400225000: Clindamycin phosphate 900mg/6ml injection solution 6mL vial (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2529325016 Clindamycin phosphate 900mg/6ml injection solution 6mL vial (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2532714017 Clindamycin phosphate 900mg/6ml injection solution 6mL vial en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2536647018 Clindamycin phosphate 900mg/6ml injection en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3667551000005117 clindamycinphosphat 900 mg/6 ml injektionsvæske, opløsning, hætteglas a 6 ml da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    clindamycinphosphat 900 mg/6 ml injektionsvæske, opløsning, hætteglas a 6 ml Is a clindamycinphosphat 150 mg/ml injektionsvæske, opløsning, ampul a 6 ml false Inferred relationship Some
    clindamycinphosphat 900 mg/6 ml injektionsvæske, opløsning, hætteglas a 6 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Clindamycin (substance) false Inferred relationship Some
    clindamycinphosphat 900 mg/6 ml injektionsvæske, opløsning, hætteglas a 6 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Substance with macrolide structure and antibacterial mechanism of action (substance) false Inferred relationship Some
    clindamycinphosphat 900 mg/6 ml injektionsvæske, opløsning, hætteglas a 6 ml Has manufactured dose form injektionsvæske false Inferred relationship Some
    clindamycinphosphat 900 mg/6 ml injektionsvæske, opløsning, hætteglas a 6 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Baktericid false Inferred relationship Some
    clindamycinphosphat 900 mg/6 ml injektionsvæske, opløsning, hætteglas a 6 ml Is a Product containing clindamycin in parenteral dose form (medicinal product form) false Inferred relationship Some
    clindamycinphosphat 900 mg/6 ml injektionsvæske, opløsning, hætteglas a 6 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Clindamycin phosphate false Inferred relationship Some
    clindamycinphosphat 900 mg/6 ml injektionsvæske, opløsning, hætteglas a 6 ml Has manufactured dose form Solution for injection false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start